Dilation Capital Management’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Sell
32,232
-18,035
-36% -$6.77M 4.74% 8
2026
Q1
$14.2M Sell
50,267
-6,870
-12% -$1.99M 7.11% 4
2025
Q4
$16.9M Buy
57,137
+13,042
+30% +$3.93M 7.77% 3
2025
Q3
$10.9M Sell
44,095
-31,615
-42% -$6.37M 5.38% 8
2025
Q2
$11.8M Buy
+75,710
New +$8.05M 6.3% 5

Other funds holding CLS

Dilation Capital Management's CLS Position: Q2 2026 in Review

Dilation Capital Management reduced its Celestica (CLS) stake by 36% in Q2 2026, selling an estimated $6.77M and leaving 32,232 shares worth $11.8M. The position accounts for 4.74% of the portfolio, ranked #8.

Dilation Capital Management first reported a position in CLS in Q2 2025 and has held it in 5 quarters since. The position peaked at $16.9M in Q4 2025. 875 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • Dilation Capital Management held 32,232 shares of Celestica worth $11.8M as of Q2 2026.
  • Dilation Capital Management sold 18,035 Celestica shares in Q2 2026, an estimated $6.77M.
  • Celestica made up 4.74% of Dilation Capital Management's portfolio in Q2 2026, its #8 holding.
  • Dilation Capital Management first reported a position in Celestica in Q2 2025 and has held it in 5 quarters since.
  • Dilation Capital Management's Celestica position peaked at $16.9M in Q4 2025.
  • 875 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Dilation Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.